- Home
- WPP vs RGEN Comparison
WPP vs RGEN Comparison
Compare WPP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- RGEN
- Stock Information
- Founded
- WPP 1985
- RGEN 1981
- Country
- WPP United Kingdom
- RGEN United States
- Employees
- WPP N/A
- RGEN N/A
- Industry
- WPP Advertising
- RGEN Medical/Dental Instruments
- Sector
- WPP Consumer Discretionary
- RGEN Health Care
- Exchange
- WPP Nasdaq
- RGEN Nasdaq
- Market Cap
- WPP 8.4B
- RGEN 8.0B
- IPO Year
- WPP N/A
- RGEN N/A
- Fundamental
- Price
- WPP $39.79
- RGEN $126.50
- Analyst Decision
- WPP Hold
- RGEN Buy
- Analyst Count
- WPP 1
- RGEN 12
- Target Price
- WPP N/A
- RGEN $172.67
- AVG Volume (30 Days)
- WPP 294.8K
- RGEN 815.5K
- Earning Date
- WPP 02-27-2025
- RGEN 04-29-2025
- Dividend Yield
- WPP 3.00%
- RGEN N/A
- EPS Growth
- WPP 389.11
- RGEN N/A
- EPS
- WPP 0.62
- RGEN N/A
- Revenue
- WPP $18,454,623,978.00
- RGEN $650,429,000.00
- Revenue This Year
- WPP N/A
- RGEN $13.93
- Revenue Next Year
- WPP $1.46
- RGEN $14.35
- P/E Ratio
- WPP $12.51
- RGEN N/A
- Revenue Growth
- WPP N/A
- RGEN 4.88
- 52 Week Low
- WPP $31.52
- RGEN $102.97
- 52 Week High
- WPP $57.37
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- WPP 58.31
- RGEN 44.61
- Support Level
- WPP $38.46
- RGEN $123.10
- Resistance Level
- WPP $40.79
- RGEN $135.47
- Average True Range (ATR)
- WPP 0.47
- RGEN 6.98
- MACD
- WPP 0.26
- RGEN -0.97
- Stochastic Oscillator
- WPP 66.22
- RGEN 25.20
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.